SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too low.

Griffin, G; Hewison, M; Hopkin, J; Kenny, RA; Quinton, R; Rhodes, J; Subramanian, S; Thickett, D (2021) Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too low. Clin Med (Lond), 21 (1). e48-e51. ISSN 1473-4893 https://doi.org/10.7861/clinmed.2020-0858
SGUL Authors: Griffin, George Edward

[img]
Preview
PDF Published Version
Available under License ["licenses_description_publisher" not defined].

Download (177kB) | Preview

Abstract

There is growing evidence linking vitamin D deficiency with risk of COVID-19. It is therefore distressing that there is major disagreement about the optimal serum level for 25-hydroxyvitamin D (25(OH)D) and appropriate supplement dose. The UK Scientific Advisory Committee for Nutrition has set the lowest level for defining sufficiency (10 ng/ml or 25 nmol/L) of any national advisory body or scientific society and consequently recommends supplementation with 10 micrograms (400 IU) per day. We have searched for published evidence to support this but not found it. There is considerable evidence to support the higher level for sufficiency (20 ng/ml or 50 nmol/L) recommended by the European Food Safety Authority and the American Institute of Medicine and hence greater supplementation (20 micrograms or 800 IU per day). Serum 25(OH)D concentrations in the UK typically fall by around 50% through winter. We believe that governments should urgently recommend supplementation with 20-25 micrograms (800-1,000 IU) per day.

Item Type: Article
Additional Information: © Royal College of Physicians 2021. All rights reserved.
Keywords: COVID-19, guidelines, vitamin D, COVID-19, Dietary Supplements, Dose-Response Relationship, Drug, Humans, Pandemics, SARS-CoV-2, Vitamin D, Vitamin D Deficiency, Vitamins, Humans, Vitamin D Deficiency, Vitamins, Vitamin D, Dose-Response Relationship, Drug, Dietary Supplements, Pandemics, COVID-19, SARS-CoV-2, vitamin D, COVID-19, guidelines, General Clinical Medicine, 1103 Clinical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Clin Med (Lond)
ISSN: 1473-4893
Language: eng
Dates:
DateEvent
21 January 2021Published
6 November 2020Published Online
Publisher License: Publisher's own licence
PubMed ID: 33158957
Web of Science ID: WOS:000712339500011
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113868
Publisher's version: https://doi.org/10.7861/clinmed.2020-0858

Actions (login required)

Edit Item Edit Item